Iloperidone: a new option for the treatment of schizophrenia. - Wikidata - awgldk - TriplyDB

Iloperidone: a new option for the treatment of schizophrenia.

Iloperidone: a new option for the treatment of schizophrenia.

http://www.wikidata.org/entity/Q37641995

about

The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Atypical antipsychotic tolerability and switching strategies in bipolar disorder.Treatment strategies for dosing the second generation antipsychotics.

P2860

Q33619940-40FDD6F0-9CB3-4279-B2B2-425F61CC7F37 Q37781370-470540EB-5246-450F-BF30-9D3CD3981806 Q37852818-500090F3-828B-4BF2-9D44-10966CCE9C9D

P2860

Iloperidone: a new option for the treatment of schizophrenia.

http://www.wikidata.org/entity/Q37641995

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Iloperidone: a new option for the treatment of schizophrenia.

@en

Iloperidone: a new option for the treatment of schizophrenia.

@nl

type

label

Iloperidone: a new option for the treatment of schizophrenia.

@en

Iloperidone: a new option for the treatment of schizophrenia.

@nl

prefLabel

Iloperidone: a new option for the treatment of schizophrenia.

@en

Iloperidone: a new option for the treatment of schizophrenia.

@nl

P1433

Q37641995-6254404C-EEA1-4FCE-B755-F2C9FD041538

P1476

Q37641995-97218319-8EEB-40B5-A188-23C9852C8DAB

P2093

Q37641995-BAA6B4F7-D2B1-493B-9938-0E1F63144A16

P2860

Q37641995-01259EF2-86F2-4F6E-A531-01907E8809E6

Q37641995-0563DD3E-0774-42C0-B4E4-58A281C2183E

Q37641995-08B5EF6A-15C8-4D7B-AB5F-4862F9A9A2DF

Q37641995-10A78404-5CDC-40C6-BAC6-8E4DB532E8A9

Q37641995-117B3780-7299-44F3-A5D3-7158BB9617F8

Q37641995-1E6343EC-9CC6-4BD0-8FB1-F42FF8494631

Q37641995-1FDBE4AC-88C1-441D-A6DD-27064CDB15E3

Q37641995-225EFDE3-0AB6-40E9-B17F-27118A033166

Q37641995-243E94A5-D15F-4E0D-92C8-46607C8E5A2E

Q37641995-3060D149-D8CE-49D7-B100-3966E73E9BD1

P304

Q37641995-9444455F-4F7F-48B5-B782-8FF728797D91

P31

Q37641995-5B67AA9E-C7FD-416C-8DB7-1F4EB799251C

P356

Q37641995-8786C131-9AD2-44E1-B413-2CCED6D1EE14

P433

Q37641995-DF662205-9464-4D8C-8AC5-F3D0112347CC

P478

Q37641995-95B5E56F-EAA2-4723-8467-472CDA9445B6

P577

Q37641995-B915B80A-E90C-41ED-8DF6-D717F456A566

P698

Q37641995-A61FAA59-81A0-4ABB-9B15-8B48871F0E7C

P921

Q37641995-7D51DDEA-F232-4CF7-BB1C-3C80C3EE3695

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Iloperidone: a new option for the treatment of schizophrenia.

@en

P2093

Andrew J Cutler

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of the prevalence of schizophrenia.

The Economic Burden of Schizophrenia in the United States in 2002

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic

Ciliary neurotrophic factor

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Drug-induced prolongation of the QT interval.

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.

Catching up on schizophrenia: natural history and neurobiology.

P304

1727-1741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.09.119

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19951132

http://www.w3.org/2001/XMLSchema#string

P921